Mental Health Concerns for Children Approaching National Health Emergency in the U.S.
October 04, 2023 14:38 ET
|
Omada Foundation for Children
LAGUNA BEACH, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Mental health is the top pediatric safety concern in the United States for 2023, according to a new report from U.S. patient safety and...
Dextromethorphan Market revenue to reach USD 550 Million by 2035, says Research Nester
September 20, 2023 07:30 ET
|
Research Nester
New York, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The global dextromethorphan market size is slated to expand at ~4% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 550...
Patient Return Electrodes Market revenue to surpass USD 343 Million by 2035, says Research Nester
August 24, 2023 05:00 ET
|
Research Nester
New York, Aug. 24, 2023 (GLOBE NEWSWIRE) -- The global patient return electrodes market size is poised to grow at a CAGR of over ~7% from 2023 to 2035. The market is anticipated to garner a revenue...
Fecal Calprotectin Test Market revenue to hit USD 350 Million by 2035, says Research Nester
August 23, 2023 07:30 ET
|
Research Nester
New York, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The global fecal calprotectin test market size is predicted to grow at a CAGR of over ~12% from 2023 to 2035. The market is projected to garner a revenue...
Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
July 31, 2023 08:30 ET
|
Globus Medical
AUDUBON, Pa., July 31, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the MARVEL™ Growing Rod...
Catalyst Pharmaceuticals Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
July 19, 2023 06:00 ET
|
Catalyst Pharmaceuticals, Inc.
Vamorolone is a Promising Best-In-Class Dissociative Anti-Inflammatory Steroid Treatment for Duchenne Muscular Dystrophy Synergistic Novel Asset Leverages Catalyst's Expertise and Bolsters...
Ensemble pour l'espoir : Bunzl récolte des fonds records pour un traitement pédiatrique révolutionnaire des tumeurs cérébrales
July 13, 2023 14:25 ET
|
Bunzl Canada Inc
BURLINGTON, Ontario, 13 juill. 2023 (GLOBE NEWSWIRE) -- Bunzl Canada est fier d'avoir organisé la 23e édition annuelle du tournoi de golf Ripple of Hope en soutien au Centre de recherche sur les...
Swinging for Hope – Bunzl Raises Record Funds for Revolutionary Pediatric Brain Tumour Treatment
July 13, 2023 14:25 ET
|
Bunzl Canada Inc
BURLINGTON, Ontario, July 13, 2023 (GLOBE NEWSWIRE) -- Bunzl Canada is proud to have hosted its 23rd annual Ripple of Hope golf tournament in support of the Arthur & Sonia Labatt Brain Tumour...
Cardiometabolic Health Congress (CMHC) Launches Focused Digital Education Hubs
July 13, 2023 11:00 ET
|
Cardiometabolic Health Congress
Boca Raton, FL, July 13, 2023 (GLOBE NEWSWIRE) -- The digital education from worldwide cardiometabolic event leader CMHC has undergone a reorganization. A vast collection of webinars, CME...
Catalyst Pharmaceuticals to License North American Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
June 20, 2023 06:00 ET
|
Catalyst Pharmaceuticals, Inc.
Vamorolone is Currently Under Review with the FDA (PDUFA Date of October 26, 2023) for the Treatment of Duchenne Muscular Dystrophy, a Rare Neuromuscular Disease FDA has Granted Fast Track and Orphan...